Wilms Tumor Treatment Market

Wilms Tumor Treatment Market Overview

Wilms Tumor also known as “Nephroblastoma” is a rare type of kidney cancer generally found in children. Most often under the age of seven, affecting mostly to the children. In an embryo, it develops from immature cells, which are involved in the child’s kidney while they are present in the womb. At the time of birth, the cells are usually disappearing but in some cases, primitive kidneys cells clusters can be found. These cause abnormalities of the genitals, aniridia and can create a condition where one side of the body in child slightly larger than the other side (hemihypertrophy). The symptoms of the Wilms tumor in the children are- painless swollen abdomen, a large lump in the abdomen of a child. Occasionally, the tumor may bleed in child’s urine which can irritate the kidney. It may be painful. The blood pressure may be raised in child, upset stomach, weight loss or a lack of appetite, the child may feel tired and also have a high fever.

Over the last 25 years, for the treatment of Wilms tumor, a great deal of progress has been made. Surgery, chemotherapy and sometimes radiation therapy is used for the treatment for the Wilms tumor. Treatments vary the stage of cancer. Treatment of Wilms tumor begins with surgery, which is a common treatment usually performed by either a pediatric surgeon or a pediatric urologist. Surgery includes removing part of the affected kidney, removing the affected kidney and surrounding tissue and removing all or part of both kidneys etc. Chemotherapy uses powerful drugs in combination to kill cancer cells. Chemotherapy used to shrink the tumor before surgery and to kill the tumor cells after surgery. Radiation uses high-energy beams depending on the stage of the tumor. Wilms tumor treatment also includes the possible side effects, the type, stage and histology of the tumor, the child and family’s preference and the child’s overall health.

Wilms Tumor Treatment Market: Drivers and Restrains

Wilms tumor treatment market is growing due to increasing incidence of new-born, technological advanced therapies, which act as a driver to the global wilms tumor treatment market. Lack of skill healthcare professionals, rich experience in using these advanced technologies, high cost associated with the diagnosis and treatment procedure are expected to act as a restraint to the Wilms tumor treatment market.

Wilms Tumor Treatment Market: Overview

The Wilms Tumor Treatment market is expected to grow at a healthy growth rate during the forecast period.

Wilms Tumor Treatment Market: Regional overview

On the basis of regional presence wilms tumor treatment market is segmented into regions namely, North America, Latin America, Western Europe, Eastern Europe, Japan, Asia-Pacific excluding Japan, Middle East and Africa. With around 500 new cases of Wilms tumors are diagnosed in the U.S. each year which constitutes around 5% of all pediatric cancers. North America remains the largest market followed by Western Europe and Asia Pacific excluding Japan.

Market: Key Players

Some of the players in the Wilms tumor treatment market includeBayer HealthCare LLC, F. Hoffmann-La Roche Ltd., Pfizer Inc., Sanofi Pasteur Inc., Merck & Co. Inc. and MediLexicon International Ltd, Bristol-Myers Squibb, APOTEX Inc.and others.

The report covers exhaustive analysis on

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Wilms Tumor Treatment Market: Segmentation

Wilms tumor treatment market is classified on the basis of the drugs and the distribution channel.

By drug type, the global Wilms tumor treatment market is segmented into–

• Dactinomycin (Cosmegen)
• Doxorubicin (Adriamycin)
• Vincristine (Vincasar PFS, Oncovin)
• Cyclophosphamide (Cytoxan, Neosar)
• Etoposide (Toposar, VePesid)
• Irinotecan (Camptosar)

By distribution channel, the global Wilms tumor treatment market is segmented into

• Hospital Pharmacies
• E-commerce
• Drug stores
• Retail pharmacy
• Others